William E Gillanders

Trials

Studies that name William E Gillanders as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT05111353 · Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery

  Washington University School of Medicine · active not recruiting · Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas · principal investigator
• Ph1
  NCT03956056 · Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

  Washington University School of Medicine · terminated · Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas · principal investigator
• N/A
  NCT03914872 · Expanded Access Neoantigen Vaccine in Solid Tumors

  Washington University School of Medicine · no longer available · Solid Tumor, Adult · principal investigator
• Ph2
  NCT03606967 · Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

  National Cancer Institute (NCI) · recruiting · Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma · principal investigator
• Ph2
  NCT02883062 · Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

  National Cancer Institute (NCI) · active not recruiting · Invasive Breast Carcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7 · principal investigator
• Ph1
  NCT02348320 · Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

  Washington University School of Medicine · completed · Triple Negative Breast Cancer, Triple-Negative Breast Cancer, Triple Negative Breast Neoplasms · principal investigator
• N/A
  NCT00355316 · A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

  Washington University School of Medicine · completed · Breast Neoplasms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Career Enhancement Program
  P50CA272213 · NCI · WASHINGTON UNIVERSITY · fiscal years 2023 to 2026 · $189,788 awarded in 2026
  Same name and institution; not confirmed by an ID
• Development of novel neoantigen-based spherical nucleic acid immunotherapeutics
  R01CA302883 · NCI · WASHINGTON UNIVERSITY · fiscal years 2026 · $562,550 awarded in 2026
  Same name and institution; not confirmed by an ID
• Surgical Oncology Basic Science and Translational Research Training Program
  T32CA009621 · NCI · WASHINGTON UNIVERSITY · fiscal years 2014 to 2026 · $251,600 awarded in 2026
  Same name and institution; not confirmed by an ID
• Molecular, Cellular, and Tissue Characterization Unit
  U2CCA233303 · NCI · WASHINGTON UNIVERSITY · fiscal years 2018 to 2023 · $349,813 awarded in 2023
  Same name and institution; not confirmed by an ID
• Targeting Neoantigens in Triple Negative Breast Cancer
  R01CA240983 · NCI · WASHINGTON UNIVERSITY · fiscal years 2019 to 2023 · $625,110 awarded in 2023
  Same name and institution; not confirmed by an ID
• Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
  P50CA196510 · NCI · WASHINGTON UNIVERSITY · fiscal years 2016 to 2020 · $410,431 awarded in 2020
  Grant number is on one of their registry trials
• SCT PROBES FOR PATHOGEN IMMUNITY
  R01AI055849 · NIAID · WASHINGTON UNIVERSITY · fiscal years 2014 · $376,200 awarded in 2014
  Same name and institution; not confirmed by an ID
• Peripheral Blood Molecular Staging of Breast Cancer
  R01CA109058 · NCI · WASHINGTON UNIVERSITY · fiscal years 2006 to 2010 · $234,822 awarded in 2010
  Same name and institution; not confirmed by an ID
• Molecular detection of breast cancer in peripheral blood
  K23CA093419 · NCI · WASHINGTON UNIVERSITY · fiscal years 2002 to 2006 · $134,946 awarded in 2006
  Same name and institution; not confirmed by an ID
• PEPTIDE MEDIATED IMMUNOTHERAPY IN TRANSPLANTATION
  F32AI008926 · NIAID · WASHINGTON UNIVERSITY · fiscal years 1994 to 1995 · $31,200 awarded in 1995
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
  UM1CA186704 · NCI · DUKE UNIVERSITY · PI JAMES L. ABBRUZZESE, ELIZABETH CLAIRE DEES, Andrea Wang-Gillam · fiscal years 2014 to 2019
  Named on NCT03606967, NCT02883062
• Supplement to Extend Funds for Grant #UM1CA186689 VICKtOrY Early Clinical Trials Consortium
  UM1CA186689 · NCI · YALE UNIVERSITY · PI Patricia M. LoRusso · fiscal years 2014 to 2026
  Named on NCT02883062